利妥昔单抗治疗成人难治性原发性膜性肾病的临床分析

冯琳鸿, 王亚琨, 吴茜茜, 朱迎春, 白寿军

Clinical analysis of rituximab for adult refractory primary membranous nephropathy

FENG Linhong, WANG Yakun, WU Qianqian, ZHU Yingchun, BAI Shoujun

表2 18例难治性PMN患者既往治疗经过及疗效评价

Tab 2 Previous treatment processes and efficacy evaluation of 18 patients with refractory PMN

No. Age at diagnosis/year Gender Time of treatment/month Previous treatment process Use of RAAS antagonist Efficacy evaluation 1 30 Male 12 GC+CTX+CsA Yes Unrelieved 2 61 Female 60 GC+CsA+TAC Yes Unrelieved 3 44 Male 72 GC+CTX+TAC No Unrelieved 4 74 Female 114 GC+CsA+TAC No Recurrence 5 76 Male 57 GC+CsA+TAC Yes Unrelieved 6 72 Male 12 GC+CTX Yes Unrelieved 7 78 Female 13 GC+CsA Yes Recurrence 8 63 Male 20 GC+CTX+CsA Yes Unrelieved 9 57 Male 18 GC+CsA+TAC No Unrelieved 10 57 Female 90 GC+CsA Yes Recurrence 11 65 Female 18 GC+CsA Yes Recurrence 12 79 Female 48 GC+CsA+TAC Yes Unrelieved 13 36 Male 17 GC+CTX+TAC Yes Recurrence 14 70 Male 28 GC+TAC Yes Unrelieved 15 21 Female 36 GC+CsA No Recurrence 16 54 Male 12 GC+CsA No Unrelieved 17 60 Male 14 GC+CTX+CsA Yes Unrelieved 18 50 Male 12 GC+TAC No Recurrence